Metraipolis › archive › dc_283d2f92e127

Repurposing Mercaptopurine Through Collateral Lethality to Treat Cancers with Somatic RB1-NUDT15 Loss — Europe PMC PMID:40904703

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40904703
DOI
10.1002/mco2.70361
License (as archived)
solo-consultazione
Archived
2026-11-10T05:13:15.729Z
SHA-256 of the archived text
46bfe55c0651d8e8244992fa221c304bcad0ccb56ddbab0e31186345958947fc
Stable URL of this page
https://metraipolis.com/documento/dc_283d2f92e127

How to cite

Repurposing Mercaptopurine Through Collateral Lethality to Treat Cancers with Somatic RB1-NUDT15 Loss — Europe PMC PMID:40904703 — Europe PMC (en), https://europepmc.org/article/MED/40904703 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_283d2f92e127 (Metraipolis archive dc_283d2f92e127, sha256 46bfe55c0651d8e8244992fa221c304bcad0ccb56ddbab0e31186345958947fc)
BibTeX
@misc{dc283d2f92e127,
  title = {Repurposing Mercaptopurine Through Collateral Lethality to Treat Cancers with Somatic RB1-NUDT15 Loss — Europe PMC PMID:40904703},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40904703},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_283d2f92e127; sha256 46bfe55c0651d8e8244992fa221c304bcad0ccb56ddbab0e31186345958947fc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40904703. Agents can read the archived copy with the MCP tool read_document.